J9360 HCPCS Level II code: Injection, vinblastine sulfate, 1 mg
J9360 is the HCPCS code for “Injection, vinblastine sulfate, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9360Injection, vinblastine sulfate, 1 mg
Short description: Vinblastine sulfate inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J9360 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1986
Where J9360 sits
- 1J codesDrugs administered other than orally
- 2Active code J9360Injection, vinblastine sulfate, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9360 mean?
J9360 is the HCPCS code for “Injection, vinblastine sulfate, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9360?
CMS lists J9360’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9360
All J codesJ9354Injection, ado-trastuzumab emtansine, 1 mgJ9355Injection, trastuzumab, excludes biosimilar, 10 mgJ9356Injection, trastuzumab, 10 mg and hyaluronidase-oyskJ9357Injection, valrubicin, intravesical, 200 mgJ9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mgJ9359Injection, loncastuximab tesirine-lpyl, 0.075 mgJ9361Injection, efbemalenograstim alfa-vuxw, 0.5 mgJ9362Injection, trabectedin, 0.01 mgJ9370Vincristine sulfate, 1 mgJ9371Injection, vincristine sulfate liposome, 1 mgJ9376Injection, pozelimab-bbfg, 1 mgJ9380Injection, teclistamab-cqyv, 0.5 mg